Lionco Pharmaceutical Group Co.,Ltd.

SHSE:603669 Stok Raporu

Piyasa değeri: CN¥4.0b

Lionco Pharmaceutical GroupLtd Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Ling Ping Tao

İcra Kurulu Başkanı

CN¥660.0k

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliği6.8%
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresiVeri yok

Son yönetim güncellemeleri

Recent updates

Lionco Pharmaceutical GroupLtd (SHSE:603669) Has Debt But No Earnings; Should You Worry?

Oct 29
Lionco Pharmaceutical GroupLtd (SHSE:603669) Has Debt But No Earnings; Should You Worry?

Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

May 10
Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

There's Reason For Concern Over Lionco Pharmaceutical Group Co.,Ltd.'s (SHSE:603669) Massive 28% Price Jump

Mar 12
There's Reason For Concern Over Lionco Pharmaceutical Group Co.,Ltd.'s (SHSE:603669) Massive 28% Price Jump

CEO

Ling Ping Tao (54 yo)

no data

Görev süresi

CN¥660,000

Tazminat

Ms. Ling Ping Tao is General Manager of Lionco Pharmaceutical Group Co.,Ltd. and serves as its Chairman of the Board.